# Assessment of Antimicrobial Transition Errors from Hospitals to Skilled Nursing Facilities

**Authors:** Amy Y Kang, Guarina A Garcia Delgado, Ashley Nguyen, Maddie Yeh, Tracy Ly, Richard Beuttler, Abisay Ortega, Donna Phan Tran, Evelyn Flores, Charis Tjoeng, Andrew Bishop, Praneet Kalkat, Loren G Miller

PMC · DOI: 10.1093/ofid/ofag111 · Open Forum Infectious Diseases · 2026-03-10

## TL;DR

This study found that nearly one-third of patients moving from hospitals to skilled nursing facilities had antimicrobial transition errors, which could lead to poor infection outcomes.

## Contribution

The study is one of the first to assess antimicrobial transition errors in patients transferred to skilled nursing facilities and identifies a potential link to adverse outcomes.

## Key findings

- Transition errors occurred in 29% of patients transitioning from hospitals to skilled nursing facilities.
- Common medications associated with errors included penicillin, tetracycline, and daptomycin.
- Older age was the only independent predictor of poor infection outcomes.

## Abstract

More than 1 million Americans reside in skilled nursing facilities (SNFs). Antimicrobial transition errors among patients transferred from hospital to SNFs pose safety risks and may lead to poor outcomes, but data on such errors are limited.

We conducted a retrospective cohort study of infectious diseases clinics from 1 June 2020 through 30 November 2023 at the Los Angeles County Department of Health Services, a large safety-net health system. We performed logistic regression analyses to identify factors associated with antimicrobial transition errors and poor infection outcomes.

We screened records of 6865 clinic patients, among whom 112 were SNF residents who were receiving post–hospital discharge antimicrobials. Mean age was 62 years, 37% were female, and 57% were Hispanic/Latino. Transition errors occurred in 32 (29%) patients. Common medications associated with errors were penicillin class (39%), tetracycline class (38%), and daptomycin (36%). In our multivariable model, age, Charlson Comorbidity Index score, number of medications, Centers for Medicare & Medicaid Services SNF rating, and therapy duration were not significantly associated with transition errors. Older age was the only independent predictor of poor infection outcome (P & .02). There was a nonsignificant trend between antimicrobial transition errors and poor infection outcome (odds ratio, 1.63 [95% confidence interval, .58–4.81]).

Nearly one-third of patients transitioning from hospitals to SNFs on antimicrobials experienced ≥1 antimicrobial transition error. We did not identify risk factors for antimicrobial transition errors. The trend toward an association between antibiotic transition errors and poor infection outcomes warrants further investigation in more robust data sets.

In a multicenter survey of infectious diseases clinics, nearly one-third of skilled nursing home residents experienced medication errors posthospitalization. A potential association between antibiotic transition errors and adverse infection outcomes may exist and should be explored further in studies with larger, more robust data sets.

## Linked entities

- **Chemicals:** penicillin (PubChem CID 2349), tetracycline (PubChem CID 54675776), daptomycin (PubChem CID 21585658)

## Full-text entities

- **Diseases:** skin (MESH:D012871), ID (MESH:D003141), Comorbidity (MESH:D004194), CCI (MESH:C566784), kidney dysfunction (MESH:D007674), death (MESH:D003643), bone and joint infection (MESH:D001847), human immunodeficiency virus (MESH:D015658), infection (MESH:D007239), Uncontrolled diabetes (MESH:D003920), hepatitis C infection (MESH:D006526)
- **Chemicals:** daptomycin (MESH:D017576), penicillin (MESH:D010406), vancomycin (MESH:D014640), imipenem (MESH:D015378), minocycline (MESH:D008911), aminoglycoside (MESH:D000617), nafcillin (MESH:D009254), ertapenem (MESH:D000077727), Cephalosporins (MESH:D002511), TMP-SMX (MESH:D015662), tetracycline (MESH:D013752), amoxicillin (MESH:D000658), meropenem (MESH:D000077731), azoles (MESH:D001393), oxacillin (MESH:D010068), rifamycin (MESH:C023808), carbapenems (MESH:D015780), ceftriaxone (MESH:D002443), omadacycline (MESH:C000591640)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12994470/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12994470/full.md

---
Source: https://tomesphere.com/paper/PMC12994470